Articles related to BRAIN INJURY/CONCUSSION

Approximately one in four patients without observable responses to commands demonstrated cognitive activity on fMRI or EEG, suggesting a higher prevalence of covert consciousness than previously recognized.

Amantadine emerges as the pharmacologic agent with the most support for improving cognitive impairment after TBI, while cognitive rehabilitation interventions demonstrate substantial evidence for enhancing neurocognitive function and reducing functional limitations.

The study found that andexanet alfa significantly improves hemostatic efficacy in patients with intracerebral hemorrhage on factor Xa inhibitors but increases the risk of thrombotic events. These findings highlight the need for careful patient selection and monitoring when considering andexanet alfa in clinical practice.

Dr. Mathew Rolando’s tragic incident while scuba diving underlines the critical importance of recognizing and promptly treating decompression sickness and other dive-related emergencies to mitigate fatal outcomes.

This study highlights the potential benefits of early surgical intervention for patients with lobar intracerebral hemorrhages, demonstrating improved functional outcomes and reduced mortality rates compared to medical management alone.

In recent research, elevated levels of a brain repair protein were found in former NFL athletes, suggesting ongoing inflammation and repair years after their careers. This highlights the need for continued monitoring and research into treatments for traumatic brain injuries.